CBT
BIVV

Capital Bank & Trust’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Capital Bank & Trust’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-77
Closed -$4K – 725
2017
Q4 		$4K Hold
77
– – ﹤0.01% 624
2017
Q3 		$4K Hold
77
– – ﹤0.01% 564
2017
Q2 		$5K Buy
+77
New +$4.38K ﹤0.01% 512

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Capital Bank & Trust's BIVV Position: Q1 2018 in Review

Capital Bank & Trust sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 77 shares — an estimated $4K sold.

Capital Bank & Trust first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $5K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Capital Bank & Trust reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Capital Bank & Trust sold 77 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $4K.
  • Capital Bank & Trust first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • Capital Bank & Trust's Bioverativ Inc. Common Stock position peaked at $5K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Capital Bank & Trust's 13F filing for Q1 2018, filed 15 May 2018.